Prestige BioPharma Limited (KRX:950210)
12,580
-210 (-1.64%)
At close: Nov 14, 2025
-1.64% (1Y)
| Market Cap | 151.20B |
| Revenue (ttm) | 14.33B |
| Net Income (ttm) | 22.30B |
| Shares Out | 12.02M |
| EPS (ttm) | 370.20 |
| PE Ratio | 33.98 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 112,839 |
| Average Volume | 141,314 |
| Open | 12,650 |
| Previous Close | 12,790 |
| Day's Range | 12,350 - 13,000 |
| 52-Week Range | 11,000 - 20,000 |
| Beta | 1.00 |
| RSI | 47.45 |
| Earnings Date | Sep 19, 2025 |